Related Experiment Video
Updated: Oct 13, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human
H Werner1, M Shalita-Chesner, S Abramovitch
1Department of Clinical Biochemistry, Tel Aviv University, Tel Aviv, 69978, Israel. hwerner@post.tau.ac.il
Abstract:
The insulin-like growth factor-I receptor (IGF-I-R) has a central role in normal cellular proliferation as well as in transformation processes. Transcription of the IGF-I receptor gene is controlled by a number of tumor suppressors, including WT1, p53, and BRCA1. It has been demonstrated that, in their wild-type form, these transcription factors can suppress the activity of the IGF-I-R promoter, with ensuing reduction in the levels of cell-surface IGF binding. On the other hand, a number of oncogenes, including mutant p53 and c-myb, and the fusion protein EWS-WT1 significantly stimulate promoter activity. Interactions between stimulatory and inhibitory transcription factors may determine the level of expression of the IGF-I-R gene and, consequently, the proliferative status of the cell.
Insights
Tumor suppressors like WT1 and p53 inhibit insulin-like growth factor-I receptor (IGF-I-R) gene activity, while oncogenes stimulate it. This balance regulates cell proliferation and transformation.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The insulin-like growth factor-I receptor (IGF-I-R) is crucial for cell growth and cancer development.
- Tumor suppressor genes (e.g., WT1, p53, BRCA1) and oncogenes influence IGF-I-R gene expression.
- Dysregulation of IGF-I-R signaling is implicated in various cancers.
Purpose of the Study:
- To investigate the regulatory mechanisms controlling IGF-I receptor gene transcription.
- To elucidate the roles of specific tumor suppressors and oncogenes in modulating IGF-I-R promoter activity.
- To understand how the interplay between transcription factors impacts cellular proliferation.
Main Methods:
- Analysis of IGF-I receptor gene promoter activity.
- Investigation of transcription factor binding and function.
- Assessment of cell-surface IGF binding levels.
Main Results:
- Wild-type tumor suppressors (WT1, p53, BRCA1) suppress IGF-I-R promoter activity.
- Oncogenes (mutant p53, c-myb) and EWS-WT1 fusion protein stimulate IGF-I-R promoter activity.
- Differential regulation by transcription factors affects IGF-I-R expression and cell proliferation.
Conclusions:
- The expression of the IGF-I receptor is tightly controlled by a balance of stimulatory and inhibitory transcription factors.
- Understanding these regulatory interactions is key to comprehending cell proliferation and transformation processes.
- Targeting IGF-I-R signaling pathways holds potential for cancer therapy.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
